platinum has been researched along with Cholangiocarcinoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, DH; Arora, M; Babiker, H; Baker, A; Barrett, M; Barro, O; Bekaii-Saab, TS; Bogenberger, J; Borad, MJ; Botrus, G; Boyle, AWR; Buetow, K; Dumbauld, C; Elliott, N; Gores, GJ; Inabinett, SR; Jones, JC; Majeed, U; Mansfield, A; Meurice, N; Mody, K; Nagalo, B; Petit, J; Smoot, R; Sonbol, MB; Starr, JS; Uson Junior, PLS; Wylie, N; Yin, J; Zhou, Y | 1 |
| Kim, H; Kim, JY; Park, KU | 1 |
| Ahn, CS; Chae, H; Chang, HM; Hong, SM; Hwang, DW; Hwang, S; Jang, SJ; Jeong, JH; Kim, D; Kim, KH; Kim, KP; Kim, SC; Kim, TW; Lee, JH; Lee, SS; Park, DH; Ryoo, BY; Song, GW; Song, TJ; Yoo, C | 1 |
| Byeon, S; Hong, JY; Jang, KT; Kang, WK; Kim, H; Kim, J; Kim, ST; Lee, J; Lim, HY; Park, JO; Park, SH; Park, YS | 1 |
| Cabrera, T; Roberge, D; Valentine, K | 1 |
5 other study(ies) available for platinum and Cholangiocarcinoma
| Article | Year |
|---|---|
Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biliary Tract Neoplasms; Cholangiocarcinoma; Circulating Tumor DNA; Cisplatin; Clone Cells; Gene Frequency; Humans; Platinum; Retrospective Studies | 2022 |
Clinical Implications of BRCA Mutations in Advanced Biliary Tract Cancer.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biliary Tract Neoplasms; Cholangiocarcinoma; Female; Humans; Male; Mutation; Platinum | 2023 |
Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biliary Tract Neoplasms; Biliary Tract Surgical Procedures; Biomarkers, Tumor; Cholangiocarcinoma; Combined Modality Therapy; DNA Damage; DNA Repair Enzymes; Exome Sequencing; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; High-Throughput Nucleotide Sequencing; Humans; Male; Middle Aged; Mutation; Platinum; Prognosis; Retrospective Studies; Survival Rate | 2019 |
Programmed Death Ligand 1 Expression as a Prognostic Marker in Patients with Advanced Biliary Tract Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Bile Duct Neoplasms; Biomarkers, Tumor; Cholangiocarcinoma; Deoxycytidine; Female; Gallbladder Neoplasms; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Palliative Care; Platinum; Prognosis; Survival Analysis; Treatment Outcome | 2021 |
Implanting metal fiducials to guide stereotactic liver radiation: McGill experience and review of current devices, techniques and complications.
Topics: Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Fiducial Markers; Gold; Humans; Liver; Liver Neoplasms; Male; Platinum; Radiography; Radiosurgery; Radiotherapy, Image-Guided; Retrospective Studies; Treatment Outcome | 2014 |